These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 12666843)

  • 1. Clinical and microbiological spectrum of meningococcal disease in adults during Hajj 2000: an implication of quadrivalent vaccination policy.
    Karima TM; Bukhari SZ; Fatani MI; Yasin KA; Al-Afif KA; Hafiz FH
    J Pak Med Assoc; 2003 Jan; 53(1):3-7. PubMed ID: 12666843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in epidemiological pattern of Meningococcal disease in Saudi Arabia. Does it constitute a new challenge for prevention and control?
    Al-Mazrou YY; Al-Jeffri MH; Abdalla MN; Elgizouli SA; Mishskas AA
    Saudi Med J; 2004 Oct; 25(10):1410-3. PubMed ID: 15494812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meningococcal disease and prevention at the Hajj.
    Borrow R
    Travel Med Infect Dis; 2009 Jul; 7(4):219-25. PubMed ID: 19717104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laboratory-confirmed invasive meningococcal disease: effect of the Hajj vaccination policy, Saudi Arabia, 1995 to 2011.
    Memish Z; Al Hakeem R; Al Neel O; Danis K; Jasir A; Eibach D
    Euro Surveill; 2013 Sep; 18(37):. PubMed ID: 24079399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The threat of meningococcal disease during the Hajj and Umrah mass gatherings: A comprehensive review.
    Yezli S
    Travel Med Infect Dis; 2018; 24():51-58. PubMed ID: 29751133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Consensus recommendation for meningococcal disease prevention for Hajj and Umra pilgrimage/travel medicine.
    Shibl A; Tufenkeji H; Khalil M; Memish Z;
    East Mediterr Health J; 2013 Apr; 19(4):389-92. PubMed ID: 23882966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meningococcal disease.
    Memish ZA; Alrajhi AA
    Saudi Med J; 2002 Mar; 23(3):259-64. PubMed ID: 11938412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meningococcal disease during the Hajj and Umrah mass gatherings.
    Yezli S; Assiri AM; Alhakeem RF; Turkistani AM; Alotaibi B
    Int J Infect Dis; 2016 Jun; 47():60-4. PubMed ID: 27062987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meningococcal disease and travel.
    Wilder-Smith A; Memish Z
    Int J Antimicrob Agents; 2003 Feb; 21(2):102-6. PubMed ID: 12615371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meningococcal infection among pilgrims visiting Madinah Al-Munawarah despite prior A-C vaccination.
    Yousuf M; Nadeem A
    J Pak Med Assoc; 2000 Jun; 50(6):184-6. PubMed ID: 10979625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serogroup B meningococcal disease during Hajj: preparing for the worst scenario.
    Khalil MK; Borrow R
    Travel Med Infect Dis; 2009 Jul; 7(4):231-4. PubMed ID: 19717106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meningococcal disease and travel.
    Memish ZA
    Clin Infect Dis; 2002 Jan; 34(1):84-90. PubMed ID: 11731951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meningococcal carriage in Umra pilgrims returning from Saudi Arabia.
    Wilder-Smith A; Paton NI; Barkham TM; Earnest A
    J Travel Med; 2003; 10(3):147-9. PubMed ID: 12757687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meningococcal disease: risk for international travellers and vaccine strategies.
    Wilder-Smith A
    Travel Med Infect Dis; 2008 Jul; 6(4):182-6. PubMed ID: 18571105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meningococcal carriage among Hajj pilgrims, risk factors for carriage and records of vaccination: a study of pilgrims to Mecca.
    Alasmari A; Houghton J; Greenwood B; Heymann D; Edwards P; Larson H; Assiri A; Ben-Rached F; Pain A; Behrens R; Bustinduy A
    Trop Med Int Health; 2021 Apr; 26(4):453-461. PubMed ID: 33415766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Meningococcemia and meningitis due to Neisseria meningitidis W135 developed in two cases vaccinated with bivalent (A/C) meningococcal vaccine].
    Turhan V; Acar A; Kılıç A; Budak S; Oncül O; Haznedaroğlu T; Görenek L
    Mikrobiyol Bul; 2010 Jul; 44(3):473-8. PubMed ID: 21063998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hajj-associated outbreak strain of Neisseria meningitidis serogroup W135: estimates of the attack rate in a defined population and the risk of invasive disease developing in carriers.
    Wilder-Smith A; Goh KT; Barkham T; Paton NI
    Clin Infect Dis; 2003 Mar; 36(6):679-83. PubMed ID: 12627350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk for meningococcal disease associated with the Hajj 2001.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Feb; 50(6):97-8. PubMed ID: 11263795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meningococcal disease in catalonia 1 year after mass vaccination campaign with meningococcal group C polysaccharide vaccine.
    Cardeñosa N; Domínguez A; Martínez A; Alvarez J; Pañella H; Godoy P; Minguell S; Camps N; Vázquez JA;
    Infection; 2003 Dec; 31(6):392-7. PubMed ID: 14735381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology and meningococcal serogroup distribution in the United States.
    Hershey JH; Hitchcock W
    Clin Pediatr (Phila); 2010 Jun; 49(6):519-24. PubMed ID: 20507868
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.